Aurobindo Pharma
India - Hyderabad
dutasteride and tamsulosin hydrochloride
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE (dutasteride and tamsulosin hydrochloride) by Aurobindo Pharma is 5-alpha reductase inhibitors [moa]. Approved for 5-alpha reductase inhibitor [epc]. First approved in 2024.
Drug data last refreshed 3d ago
5-alpha Reductase Inhibitors
5-alpha Reductase Inhibitor
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects
Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States
Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State
Worked on DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.